Loading…
Loading…
Service lines and development focus areas. Each engagement is scoped to your program—there is no one-size-fits-all catalog. Use this page to see where we are strongest; then start a scoping call.
M Analytical provides research and development services, not unregulated “research use” retail sales. Commercial product supply is governed by your agreements, geography, and applicable law.
Iterative design cycles around potency, selectivity, and off-target risk.
Scout routes that survive the next order-of-magnitude in scale and complexity.
From linear to constrained peptides and peptidomimetic design.
Purity, identity, and method development that support chemistry decisions.
Build molecules that are testable, not just potent.
Chemistry and analytical alignment for developability and safety.
Solids, salts, and early formulation risks.
R&D for ligases, E3 connectors, and linker design.
Right compounds tested in the right order.
Complexity when the biology justifies the chemistry.
Mechanism-driven design when orthosteric space is crowded or kinetics are part of the hypothesis.
Small-molecule and peptide linkers for biologics-adjacent programs.
When batch chemistry is the bottleneck, we explore modern route options.
Chemistry that supports target validation, not just a single IC50.
R&D-stage chemistry documentation that anticipates CMC and regulatory questions.
Routes that are safer, cheaper, and more reproducible at scale.
R&D choices that affect solubility, processability, and spec strategy.
Molecules built to answer PK, mass-spec, and distribution questions.
Human-in-the-loop models—never a black box replacing judgment.
Chemistry and peptide work where species, formulation route, and label constraints differ from human health.
Work product that holds up in audits and partnerships.
For how we work day to day, see Our approach and the FAQ.